Acetaminophen Overdose With NAC Dosing Calculator

Acetaminophen Overdose With NAC Dosing Calculator for Endocrinology. Each bag shows drug mass, stock withdrawal volume and final-volume infusion rate as distinct quantities. Stock must be diluted; its mL value is never a direct infusion rate. Completing the nominal bags does not establish clinical stopping criteria. Higher-risk or prolonged exposures may need a different poison-service plan.

For shared guidance on choosing a tool and documenting results, read the clinical calculator workflow.

How this calculator works

This is labeled IV ACETADOTE dose arithmetic after a clinician selects a regimen. Three bags use 150, 50 and 100 mg/kg over 1, 4 and 16 hours; the alternative two bags use 200 and 100 mg/kg over 4 and 16 hours only from 41 kg. Label doses are capped at the 100-kg amounts. Stock volume uses 200 mg/mL; pump rate uses the separately confirmed FINAL diluted volume.

When to use this calculator

For supervised hospital preparation checks after overdose assessment and the decision to give IV acetylcysteine. Suspected acetaminophen overdose needs immediate poison-service or emergency assessment; do not wait for symptoms or this calculation. The tool neither plots a nomogram nor decides whether to start, continue or stop treatment.

Inputs used

  • Treating clinician selected IV NAC regimen; pharmacy verified final diluted bag volumes and patient eligibility
  • Patient weight (kg)
  • Already selected ACETADOTE regimen
  • Pharmacy-confirmed FINAL diluted volume, bag 1 (mL)
  • Pharmacy-confirmed FINAL diluted volume, bag 2 (mL)
  • Pharmacy-confirmed FINAL diluted volume, bag 3 (mL)

Clinical interpretation

Each bag shows drug mass, stock withdrawal volume and final-volume infusion rate as distinct quantities. Stock must be diluted; its mL value is never a direct infusion rate. Completing the nominal bags does not establish clinical stopping criteria. Higher-risk or prolonged exposures may need a different poison-service plan.

Worked example

Fictional three-bag check at 60 kg: 9000, 3000 and 6000 mg, totaling 18000 mg. From 200 mg/mL stock these are 45, 15 and 30 mL. Pharmacy-confirmed final volumes of 245, 515 and 1030 mL give 245, 128.75 and 64.375 mL/hour over 1, 4 and 16 hours. These example final volumes are not universal dilution instructions.

Limitations and safety notes

Only the cited US manufacturer regimens and 200-mg/mL IV stock are represented, not oral NAC, local alternative regimens, massive-overdose escalation or patients under 5 kg. Two-bag use below 41 kg is blocked without rounding weight upward. Pharmacy must verify diluent, osmolarity, final volume and fluid restriction; this tool cannot do those checks. Hypersensitivity and fluid overload require monitoring. Label evidence above 100 kg is limited.

Frequently asked questions

Does a calculated result authorize administration?

No. It checks the entered arithmetic only. The patient-specific order, product, preparation, timing, monitoring and clinical appropriateness need separate verification.

What exactly does this workflow leave to the treating team?

Only the cited US manufacturer regimens and 200-mg/mL IV stock are represented, not oral NAC, local alternative regimens, massive-overdose escalation or patients under 5 kg. Two-bag use below 41 kg is blocked without rounding weight upward. Pharmacy must verify diluent, osmolarity, final volume and fluid restriction; this tool cannot do those checks. Hypersensitivity and fluid overload require monitoring. Label evidence above 100 kg is limited.

References

  • ACETADOTE manufacturer label revised July 2025: sections 2.4-2.5, Tables 2-3, 5-kg/41-kg eligibility, 100-kg capped masses, 200 mg/mL stock and dilution/monitoring limitations. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=472f158a-5ab9-4308-8e49-1116e6ea3d39

Editorial review and citation methodology

Maintained by the Quick Medical Calculator Editorial Team. Content record date: September 9, 2026. A content date is not evidence of independent clinical review. Individual clinical sign-off is not recorded on this page.

  • Prefer original validation studies for scoring systems and prediction tools.
  • Use current specialty society guidance, transplant allocation policy, public health guidance, or regulator resources when they govern clinical use.
  • Include limitations and safety notes when a calculator is population-specific, context-dependent, or unsuitable as a standalone decision tool.

Related reviewed calculators